Global Retirement Partners’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.1K | Buy |
+38
| New | +$2.74K | ﹤0.01% | 3853 |
|
|
2025
Q4 | $5.47K | Buy |
72
+37
| +106% | +$2.69K | ﹤0.01% | 3409 |
|
|
2025
Q3 | $2.15K | Sell |
35
-152
| -81% | -$7.92K | ﹤0.01% | 3309 |
|
|
2025
Q2 | $9.13K | Buy |
+187
| New | +$8.88K | ﹤0.01% | 2647 |
|
|
2024
Q4 | $4.29K | Buy |
95
+60
| +171% | +$2.57K | ﹤0.01% | 2753 |
|
|
2024
Q3 | $1.3K | Hold |
35
| – | – | ﹤0.01% | 3075 |
|
|
2024
Q2 | $1.07K | Hold |
35
| – | – | ﹤0.01% | 3144 |
|
|
2024
Q1 | $1.02K | Hold |
35
| – | – | ﹤0.01% | 2977 |
|
|
2023
Q4 | $1K | Hold |
35
| – | – | ﹤0.01% | 2899 |
|
|
2023
Q3 | $742 | Hold |
35
| – | – | ﹤0.01% | 2846 |
|
|
2023
Q2 | $1.42K | Sell |
35
-15
| -30% | -$734 | ﹤0.01% | 2665 |
|
|
2023
Q1 | $2.77K | Buy |
50
+15
| +43% | +$686 | ﹤0.01% | 2383 |
|
|
2022
Q4 | $1.34K | Hold |
35
| – | – | ﹤0.01% | 2500 |
|
|
2022
Q3 | $1K | Hold |
35
| – | – | ﹤0.01% | 2553 |
|
|
2022
Q2 | $1K | Hold |
35
| – | – | ﹤0.01% | 2527 |
|
|
2022
Q1 | $1K | Buy |
+35
| New | +$1.35K | ﹤0.01% | 2487 |
|
|
2021
Q4 | – | Sell |
-35
| Closed | -$1K | – | 1392 |
|
|
2021
Q3 | $1K | Hold |
35
| – | – | ﹤0.01% | 1922 |
|
|
2021
Q2 | $1K | Hold |
35
| – | – | ﹤0.01% | 1821 |
|
|
2021
Q1 | $2K | Hold |
35
| – | – | ﹤0.01% | 1659 |
|
|
2020
Q4 | $2K | Hold |
35
| – | – | ﹤0.01% | 1622 |
|
|
2020
Q3 | $2K | Hold |
35
| – | – | ﹤0.01% | 1500 |
|
|
2020
Q2 | $2K | Hold |
35
| – | – | ﹤0.01% | 1482 |
|
|
2020
Q1 | $2K | Hold |
35
| – | – | ﹤0.01% | 1433 |
|
|
2019
Q4 | $2K | Hold |
35
| – | – | ﹤0.01% | 1479 |
|
|
2019
Q3 | $1K | Hold |
35
| – | – | ﹤0.01% | 1539 |
|
|
2019
Q2 | $2K | Hold |
35
| – | – | ﹤0.01% | 1452 |
|
|
2019
Q1 | $1K | Hold |
35
| – | – | ﹤0.01% | 1477 |
|
|
2018
Q4 | $1K | Hold |
35
| – | – | ﹤0.01% | 1413 |
|
|
2018
Q3 | $2K | Hold |
35
| – | – | ﹤0.01% | 1408 |
|
|
2018
Q2 | $1K | Hold |
35
| – | – | ﹤0.01% | 1484 |
|
|
2018
Q1 | $1K | Hold |
35
| – | – | ﹤0.01% | 1434 |
|
|
2017
Q4 | $1K | Hold |
35
| – | – | ﹤0.01% | 1392 |
|
|
2017
Q3 | $1K | Hold |
35
| – | – | ﹤0.01% | 1184 |
|
|
2017
Q2 | $1K | Hold |
35
| – | – | ﹤0.01% | 1112 |
|
|
2017
Q1 | $0 | Hold |
35
| – | – | ﹤0.01% | 1133 |
|
|
2016
Q4 | $0 | Buy |
+35
| New | +$367 | ﹤0.01% | 1043 |
|
Other funds holding PTCT
RI
JT
Global Retirement Partners's PTCT Position: Q2 2026 in Review
Global Retirement Partners opened a new position in PTC Therapeutics (PTCT) in Q2 2026: 38 shares worth $3.1K. The stake represents ﹤0.01% of the portfolio and ranks #3853 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in PTCT as recently as Q4 2025.
Global Retirement Partners first reported a position in PTCT in Q4 2016 and has held it in 36 quarters since. The position peaked at $9.13K in Q2 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Global Retirement Partners held 38 shares of PTC Therapeutics worth $3.1K as of Q2 2026.
- PTC Therapeutics was a new Global Retirement Partners position in Q2 2026.
- PTC Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3853 holding.
- Global Retirement Partners first reported a position in PTC Therapeutics in Q4 2016 and has held it in 36 quarters since.
- Global Retirement Partners's PTC Therapeutics position peaked at $9.13K in Q2 2025.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.